• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
Research on related companies


Related Content

View the latest research on other companies in the sector. 

Panmure Morning Note 11-3-2016

Following the announcement yesterday that the merger with Just Retirement had received regulatory approval we anticipate relatively little interest in the figures today and much more on the outlook for the merged entity. The merger is due to complete in early April now. For the record, the headline IFRS Operating profit at £40m (-37.5%) compared to our consensus at £43m with the slight miss due to some non-recurring assumption changes that have impacted the in force profit. The final dividend of will be based on the Just Retirement final dividend of 1.1p/share adjusted for the merger thus making 0.92p/share for Partnership shareholders or 1.42p for the full year (2014: 1.5p). The Embedded Value (MCEV) NAV at 31 Dec was flat at 144p (31 Dec 2014: 144p) per share lower than our 154p per share forecast partly reflecting lower profitability that we had anticipated. The Solvency II coverage ratio was 144% better than we believe many will have anticipated, with an economic surplus of £178m. Slightly disappointing figures but largely irrelevant given the merger.

Partnership Assurance Group

  • 11 Mar 16
  • -
  • Panmure Liberum
Panmure Research - Partnership Assurance Flash 23-11-15

Just Retirement and Partnership have announced a delay to their planned nuptials. Just Retirement intends to delay the posting of the shareholder circular until the regulator (the PRA) has commented on its internal model, along with all the other insurers, in early December. Whilst it will only postpone the anticipated completion date a few weeks from late December into January we think it is disappointing given that the PRA timescale has been known about for many months. Separately following the detailed full year sales guidance provided by Partnership we are cutting our 2015F full year sales forecast from £602m to £558m which has led us to cut our 2015F IFRS Operating EPS to 9.6p/share from 10.8p/share previously. The valuation remains highly attractive with the share price at a 13% discount to our forecast Embedded Value at 31 Dec 2015 of 154p/share.

Partnership Assurance Group

  • 23 Nov 15
  • -
  • Panmure Liberum
Panmure Morning Note 20-11-15

Partnership has announced the name of its partner in the US to launch a medically underwritten immediate annuity comparable to Partnership's UK Care annuity. It is Genworth, the market leader in Long Term Care (LTC) with c25% of the US LTC in force policies. Genworth will bring brand, market leading expertise, an existing operating platform and distribution in the US. We are not adjusting our forecasts at this stage but believe that this is very positive for the longer term outlook of Partnership/JRP post the merger with Just Retirement. The product will be launched in Q1 2016. The valuation remains compelling on both Partnership and Just Retirement and we consequently maintain our Buy recommendation and 165p/share target price.

Partnership Assurance Group

  • 20 Nov 15
  • -
  • Panmure Liberum
Panmure Morning Note 05-11-15

Partnership has delivered a solid sales performance with sales at £109m (+22%) in Q3 following the introduction of the pension changes in April with good guidance for H2 (+10% on H1) and still on track to deliver £200m of Bulk sales (£92m at 9M stage with a further £60m of ‘exclusives'). Total sales in Q3 at £109m (+22%) was largely in line with consensus at £119m but below our £153m forecast reflecting lower hard to forecast Bulk sales at £24m (Q3 2014: £nil). The Bulk sales at £24m compared to our £60m forecast and consensus at £30m. Individual annuity sales at £68m (flat) compared to our £77m forecast and consensus at £73m. Following the share price fall we have upgraded our recommendation to Buy from Hold and note that the shares are now trading at a 10% discount to 30 June EV of 147p/share. In our view the shares should be trading at a premium rather than a discount to EV given the value of its new business. Buy. We anticipate that the proposed merger with Just Retirement will complete by 2015 year end.

Partnership Assurance Group

  • 05 Nov 15
  • -
  • Panmure Liberum
Panmure Morning Note 11-08-15

We are surprised by today's announcement that Partnership and Just Retirement are to merge. It's an all share agreed merger whereby each PA share will be exchanged for 0.834 new shares in Just Retirement. In effect this equates to PA being taken out at c166p per share, although we think JR's share price will be under pressure today. The top jobs (CEO and FD) have been retained by JR's management team with PA's CEO Steve Groves stepping down. There are expected to be cost synergies of c£40m pa and the cost of achieving this is c£60m. Lastly there will be an equity raise of £150m. We are slightly sceptical of the reasons for the merger (Synergies, BPA scale etc) and take PA to a Hold recommendation and lower our target price to 165p per share from 175p previously.

Partnership Assurance Group

  • 11 Aug 15
  • -
  • Panmure Liberum
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In